These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1442537)

  • 21. Report of the 2010 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2010; 50(4):471-2. PubMed ID: 20621862
    [No Abstract]   [Full Text] [Related]  

  • 22. APhA House of Delegates to address pharmacists' concerns.
    Martin S
    Am Pharm; 1991 Feb; NS31(2):19-24. PubMed ID: 2006608
    [No Abstract]   [Full Text] [Related]  

  • 23. APhA to focus on pharmacists' role in health care and on harassment guidelines.
    Flanagan ME
    Am Pharm; 1994 Feb; NS34(2):71-5. PubMed ID: 8166047
    [No Abstract]   [Full Text] [Related]  

  • 24. Draft guidelines on compounding of nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1993 Jul; 50(7):1452-61. PubMed ID: 8362883
    [No Abstract]   [Full Text] [Related]  

  • 25. Mirror to ASHP: 1942-1992.
    Anderson RD
    Am J Hosp Pharm; 1992 Aug; 49(8):1925-35. PubMed ID: 1442835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 27. Harvey A. K. Whitney Lecture. To a new beginning from converging paths.
    Godwin HN
    Am J Hosp Pharm; 1991 Aug; 48(8):1697-703. PubMed ID: 1897548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacists' knowledge, attitudes, and practices regarding influenza vaccination and treatment of pregnant women.
    Dolan SM; Cox S; Tepper N; Ruddy D; Rasmussen SA; MacFarlane K
    J Am Pharm Assoc (2003); 2012; 52(1):43-51. PubMed ID: 22257615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASHP engages on compounding.
    Traynor K
    Am J Health Syst Pharm; 2015 Mar; 72(6):428. PubMed ID: 25736933
    [No Abstract]   [Full Text] [Related]  

  • 30. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
    Blankenship C
    Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
    [No Abstract]   [Full Text] [Related]  

  • 31. Guiding pharmacists to achieve success: our profession and APhA keep the light shining.
    Tucker TL
    J Am Pharm Assoc (2003); 2008; 48(4):460-3. PubMed ID: 18653419
    [No Abstract]   [Full Text] [Related]  

  • 32. The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: AN UNSPOKEN OPPORTUNITY FOR PHARMACISTS.
    Parks KC; Bernard B; Cogdill CB
    Int J Pharm Compd; 2015; 19(5):377-80. PubMed ID: 26775444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. International Academy of Compounding Pharmacists' recommendations for state-based legislative and regulatory initiatives.
    Miller DG
    Int J Pharm Compd; 2013; 17(1):48-9. PubMed ID: 23627246
    [No Abstract]   [Full Text] [Related]  

  • 34. Report of the 2015 APhA House of Delegates.
    J Am Pharm Assoc (2003); 2015; 55(4):364-75. PubMed ID: 26161480
    [No Abstract]   [Full Text] [Related]  

  • 35. Draft guidelines on quality assurance for pharmacy-prepared sterile products.
    Am J Hosp Pharm; 1992 Feb; 49(2):407-17. PubMed ID: 1554008
    [No Abstract]   [Full Text] [Related]  

  • 36. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASHP statement on bar-code verification during inventory, preparation, and dispensing of medications.
    American Society of Health-System Pharmacists
    Am J Health Syst Pharm; 2011 Mar; 68(5):442-5. PubMed ID: 21330687
    [No Abstract]   [Full Text] [Related]  

  • 38. Report of the 2013 APhA House of Delegates.
    J Am Pharm Assoc (2003); 2013; 53(4):365-7. PubMed ID: 23892807
    [No Abstract]   [Full Text] [Related]  

  • 39. Report of the APhA and APhA-ASP Houses of Delegates.
    Bzowyckyj A; Oestreich J; Kirk LM
    J Am Pharm Assoc (2003); 2015; 55(4):340, 342-4, 346-7. PubMed ID: 26161477
    [No Abstract]   [Full Text] [Related]  

  • 40. ASHP guidelines on outsourcing sterile compounding services.
    Rinehart JR; Chan D; Cunningham M; Geller RE; Grandfield G; Heckman S; Kruzynski R; Nishizaki TT;
    Am J Health Syst Pharm; 2010 May; 67(9):757-65. PubMed ID: 20410553
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.